On the streets of Haiti, untrained vendors make a living selling medications out of plastic buckets.   The illegal sales—sometimes of knockoffs, counterfeits and expired drugs—have led to dangerous situations for some Haitians.   As part of a National Geographic project…

Industrial pollution caused by Indian pharmaceutical companies in Hyderabad is creating deadly superbugs, a major new study in the journal Infection suggests. Working together, University of Leipzig scientists and German journalists found residue of antibiotic and…

Iowa nonprofit SafeNetRx is leading the charge to combat medication waste by collecting leftover, unexpired prescription drugs from nursing homes and redistributing them to the many patients who can’t afford them.   While waste is not tracked nationwide, the EPA estimates…

In July, Uruguay will become the first country where pharmacists can legally sell recreational marijuana over the counter. Marijuana sold in pharmacies will come from fields supervised by the government, and a national registry that people must enroll in to buy the drug is…

In response to rising prescription drug costs in the US, the Pew Charitable Trusts has curated a list of 6 payment policies shown to help manage costs in other high-income countries. The policies include benchmarking against drug costs in other countries or against…

Research-based pharmaceutical companies have a bad reputation across the globe.   To repair their image while also tapping new markets among populations that are typically underserved, companies should turn “access to medicine” into a business strategy, argues Damiano de…

Two major drug distributors, McKesson Corp. and Cardinal Health, recently agreed to pay fines for their failure to report suspicious orders of controlled substances to the U.S. Drug Enforcement Agency (DEA). The settlements were announced as drug distributors come under…

Drug makers have manipulated America’s Orphan Drug Act — enacted in 1983 to help people suffering from rare diseases — for their own financial gain, according to a Kaiser Health News investigation.     To encourage development of drugs that will benefit very few patients,…

The history of modern-day drug regulations can be traced all the way back to several ancient cure-all drugs. King and toxicologist Mithridates, who ruled on the southern edge of the Black Sea from 120 to 63 BCE, invented what would later be called mithridatium as a…

Any day now, the US Senate is expected to pass the $6 billion 21st Century Cures Act, which includes a provision expanding evidence the FDA can consider when evaluating new drug treatments.   Proponents say this change will allow the FDA to speed life-saving therapies to…